Advertisement

Regulation of SMRT and N-CoR Corepressor Function

  • M. L. Privalsky
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 254)

Abstract

This review will describe how the functions of transcriptional corepressors are regulated in cells. I will focus primarily on the SMRT (Silencing Mediator of Retinoic acid and Thyroid hormone receptors) and N-CoR (Nuclear hormone receptor Co-Repressor) complexes that mediate repression by the nuclear hormone receptors (Chen and Evans 1995; Hörlein et al. 1995; Sande and Privalsky 1996). Given that these same corepressors also participate in transcriptional repression by a variety of other transcriptional factors, including PLZF, BCL-6, Myo D, CBF-1/RBP-Jk, and ETO, this review will also touch on aspects of transcriptional regulation by non-receptor transcription factors (Dhordain et al. 1997; Hong et al. 1997; Gelmetti et al. 1998; Grignani et al. 1998; Guidez et al. 1998; He et al. 1998; Kao et al. 1998; Lin et al. 1998; Lutterbach et al. 1998; Wong and Privalsky 1998a; Bailey et al. 1999).

Keywords

Nuclear Receptor Thyroid Hormone Receptor Nuclear Hormone Receptor Corepressor Complex Nuclear Receptor Corepressor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aasland R, Stewart AF, Gibson T (1996) The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sei 21: 87–88Google Scholar
  2. Bailey P, Downes M, Lau P, Harris J, Chen SL, Hamamori Y, Sartorelli V, Muscat GE (1999) The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol Endocrinol 13: 1155–1168Google Scholar
  3. Bailey PJ, Dowhan DH, Franke K, Burke LJ, Downes M, Muscat GE (1997) Transcriptional repression by COUP-TF 11 is dependent on the C-terminal domain and involves the N-CoR variant, RIP134I. J Steroid Biochem Mol Biol 63: 165–174PubMedGoogle Scholar
  4. Baniahmad A, Dressel U, Renkawitz R (1998) Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR. Mol Endocrinol 12: 504–512PubMedGoogle Scholar
  5. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, O’Malley BW (1995) The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15: 76–86PubMedGoogle Scholar
  6. Bernardini S, Melino G, Saura F, Annicchiarico-Petruzzelli M, Motti C, Cortese C, Federici G (1997) Expression of co-factors (SMRT and Trip-1) for retinoic acid receptors in human neuroectodermal cell lines. Biochem Biophys Res Commun 234: 278–282PubMedGoogle Scholar
  7. Bodwell JE, Webster JC, Jewell CM, Cidlowski JA, Hu JM, Munck A (1998) Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol 65: 91–99PubMedGoogle Scholar
  8. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D (1995) Crystal structure of the ligandbinding domain of the human nuclear receptor RXR-a. Nature 375: 377–382PubMedGoogle Scholar
  9. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753–758PubMedGoogle Scholar
  10. Burke LJ, Downes M, Laudet V, Muscat GE (1998) Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA a. Mol Endocrinol 12: 248–262PubMedGoogle Scholar
  11. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940–954PubMedGoogle Scholar
  12. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors [see comments]. Nature 377: 454–457PubMedGoogle Scholar
  13. Chen JD, Li H (1998) Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Crit Rev Eukaryot Gene Expr 8: 169–190PubMedGoogle Scholar
  14. Chen JD, Umesono K, Evans RM (1996) SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93: 7567–7571PubMedGoogle Scholar
  15. Chin WW, Carr FE, Burnside J, Darling DS (1993) Thyroid hormone regulation of thyrotropin gene expression. Recent Prog Horm Res 48: 393–414PubMedGoogle Scholar
  16. Cohen RN, Wondisford FE, Hollenberg AN (1998) Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol Endocrinol 12: 1567–1581PubMedGoogle Scholar
  17. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J (1998) Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 18: 2949–2956PubMedGoogle Scholar
  18. Damm K, Thompson CC, Evans RM (1989) Protein encoded by V-Erb A functions as a thyroid-hormone receptor antagonist. Nature 339: 593–597PubMedGoogle Scholar
  19. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR (1998) Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12: 3343–3356PubMedGoogle Scholar
  20. Dhordain P, Albagli 0, Lin RJ, Ansieau S, Quief S, Leutz A, Kerckaert JP, Evans RM, Leprince D (1997) Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci USA 94: 10762–10767PubMedGoogle Scholar
  21. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O (1998) The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3 A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 26: 4645–4651PubMedGoogle Scholar
  22. DiRenzo J, Söderstrom M, Kurokawa R, Ogliastro MH, Ricote M, Ingrey S, Hörlein A, Rosenfeld MG, Glass CK (1997) Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol 17: 2166–2176PubMedGoogle Scholar
  23. Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (1999) Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor a interacting protein. J Biol Chem 274: 15901–15907PubMedGoogle Scholar
  24. Downes M, Burke LI, Bailey PJ, Muscat GE (1996) Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res 24: 4379–4386Google Scholar
  25. Dwivedi PP, Muscat GE, Bailey PJ, Omdahl JL, May BK (1998) Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP1341. J Mol Endocrinol 20: 327–335PubMedGoogle Scholar
  26. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH (1992) Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol 6: 429–442PubMedGoogle Scholar
  27. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 18: 7185–7191PubMedGoogle Scholar
  28. Glass CK (1996) Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J Endocrinol 150: 349–357PubMedGoogle Scholar
  29. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S, Pelicci PG (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391: 815–8I8Google Scholar
  30. Guidez F, Ivins S, Zhu J, Söderström M. Waxman S, Zelent A (1998) Reduced retinoic acid-sensitivities of nuclear receptor Corepressor binding to PML- and PLZF-RARa underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91: 2634–2642Google Scholar
  31. Hammer GD. Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HA (1999) Phosphorylation of the nuclear receptor SF-I modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 3: 521–526PubMedGoogle Scholar
  32. Harding HP, Atkins GB, Jaffe AB, Sco WJ, Lazar MA (1997) Transcriptional activation and repression by RORa, an orphan nuclear receptor required for cerebellar development. Mol Endocrinol 11: 1737–1746PubMedGoogle Scholar
  33. Hassig CA, Schreiber SL (1997) Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Cheni Biol 1: 300–308Google Scholar
  34. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP (1998) Distinct interactions of PML-RARa and PLZF-RARa with co-repressors determine differential responses to RA in APL. Nat Genet 18: 126–135PubMedGoogle Scholar
  35. Hollenberg AN, Monden T. Madura JP, Lee K, Wondisford FE (1996) Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J Biol Chem 271: 28516–8520PubMedGoogle Scholar
  36. Hong SH, Privalsky ML (2000) SMRT corepressor is regulated by a MEKK-1 pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol 20: 6612–6625PubMedGoogle Scholar
  37. Hong SH, David G, Wong CW, Dejean A, Privalsky ML (1997) SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptora ( RARa) and PLZF-RARa oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94: 9028–9033Google Scholar
  38. Hong SH, Privalsky ML (1999) Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-a. J Biol Chem 274: 2885–2892PubMedGoogle Scholar
  39. Hong SH, Wong CW, Privalsky ML (1998) Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) Corepressor. Mol Endocrinol 12: 1161–1171PubMedGoogle Scholar
  40. Hörlein AJ. Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397–404PubMedGoogle Scholar
  41. Hu X, Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 93–96PubMedGoogle Scholar
  42. Huang EY, Zhang JS, Miska EA, Guenther MG, Kouzarides T, Lazar MA (2000) Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Gene Develop 14: 45 54Google Scholar
  43. Huynh KD, Bardwell VJ (1998) The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17: 2473–2484PubMedGoogle Scholar
  44. Ito M, Yuan CX, Malik S, Gu W, Fondell JD, Yamamura S, Fu ZY, Zhang X, Qin J, Roeder RG (1999) Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell 3: 361–370PubMedGoogle Scholar
  45. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB (1997) The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 11: 693–705PubMedGoogle Scholar
  46. Kao HY, Downes M, Ordentlich P, Evans RM (2000) Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Gene Develop 14: 55–66Google Scholar
  47. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM, Kadesch T (1998) A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 12: 2269–2277PubMedGoogle Scholar
  48. Katzenellenbogen BS (1996) Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54: 287–293PubMedGoogle Scholar
  49. Kimble J, Henderson S, Crittenden S (1998) Notch/LIN-12 signaling: transduction by regulated protein slicing. Trends Biochem Sci 23: 353–357PubMedGoogle Scholar
  50. Kliewer SA, Lehmann JM, Willson TM (1999) Orphan nuclear receptors: shifting endocrinology into reverse. Science 284: 757–760PubMedGoogle Scholar
  51. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor [see comments]. Nature 377: 451–454PubMedGoogle Scholar
  52. Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW (1998) Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 95: 2920–2925PubMedGoogle Scholar
  53. Lazar MA (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14: 184–193PubMedGoogle Scholar
  54. Lefstin JA, Yamamoto KR (1998) Allosteric effects of DNA on transcriptional regulators. Nature 392: 885–888PubMedGoogle Scholar
  55. Li H, Leo C, Schroen DJ, Chen JD (1997) Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol Endocrinol 11: 2025–2037PubMedGoogle Scholar
  56. Lin BC, Hong SH, Krig S, Yoh SM, Privalsky ML (1997) A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol 17: 6131–6138PubMedGoogle Scholar
  57. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811–814PubMedGoogle Scholar
  58. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18: 7176–7184PubMedGoogle Scholar
  59. Mak HY, Hoare S, Henttu PM, Parker MG (1999) Molecular determinants of the estrogen receptorcoactivator interface. Mol Cell Biol 19: 3895–3903PubMedGoogle Scholar
  60. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83: 841–850PubMedGoogle Scholar
  61. Miner JN, Yamamoto KR (1991) Regulatory crosstalk at composite response elements. Trends Biochem Sci 16: 423–426PubMedGoogle Scholar
  62. Misiti S, Schomburg L, Yen PM, Chin WW (1998) Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139: 2493–2500PubMedGoogle Scholar
  63. Muscat GE, Burke LI, Downes M (1998) The corepressor N-CoR and its variants RIP13a and RIP1341 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucleic Acids Res 26: 2899–2907PubMedGoogle Scholar
  64. Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JWR (1999) Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13: 3209–3216PubMedGoogle Scholar
  65. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395: 137–143PubMedGoogle Scholar
  66. O’Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, Clark JH (1995) An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Horm Res 50: 333–347PubMedGoogle Scholar
  67. Ordentlich P, Downes M, Xie W, Genin A, Spinner NB, Evans RM (1999) Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci USA 96: 2639–2644PubMedGoogle Scholar
  68. Park EJ, Schroen DJ, Yang M, Li H, Li L, Chen JD (1999) SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci USA 96: 3519–3524PubMedGoogle Scholar
  69. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG (1999) Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13: 3198–3208PubMedGoogle Scholar
  70. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Näär AM, Erdjument-Bromage H, Tempst P, Freedman LP (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398: 824–828PubMedGoogle Scholar
  71. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D (1995) Crystal structureGoogle Scholar
  72. of the RAR-y ligand-binding domain bound to all-trans retinoic acid. Nature 378:681–689Google Scholar
  73. Saatcioglu F, Claret FX, Karin M (1994) Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol 5: 347–359PubMedGoogle Scholar
  74. Sande S, Privalsky ML (1996) Identification of TRACs ( T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10: 813–825Google Scholar
  75. Sap J, Munoz A, Schmitt J, Stunnenberg H, Vennstrom B (1989) Repression of transcription mediated at a thyroid hormone response element by the V-Erb-A oncogene product. Nature 340: 242–244PubMedGoogle Scholar
  76. Sasaki S, Lesoon-Wood LA, Dey A, Kuwata T, Weintraub BD, Humphrey G, Yang WM, Seto E, Yen PM, Howard BH, Ozato K (1999) Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin ß gene. Embo J 18: 5389–5398PubMedGoogle Scholar
  77. Schaefi3er HJ, Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. 19: 2435–2444Google Scholar
  78. Schlesinger TK, Fanger GR, Yujiri T, Johnson GL (1998) The TAO of MEKK. Front Biosci 3: D1181–1186PubMedGoogle Scholar
  79. Schulman IG, Juguilon H, Evans RM (1996) Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol 16: 3807–3813PubMedGoogle Scholar
  80. Schulman IG, Shao G, Heyman RA (1998) Transactivation by retinoid X receptor-peroxisome proliferator-activated receptory (PPARy) heterodimers: intermolecular synergy requires only the PPARy hormone-dependent activation function. Mol Cell Biol 18: 3483–3494PubMedGoogle Scholar
  81. Seol W, Mahon MJ, Lee YK, Moore DD (1996) Two receptor interacting domains in the nuclear hormone receptor corepressor RIPI3/N-CoR. Mol Endocrinol 10: 1646–1655PubMedGoogle Scholar
  82. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998) The structural basis of estrogen receptorlcoactivator recognition and the antagonism of this interaction by Tamoxifen. Cell 95: 927–937PubMedGoogle Scholar
  83. Shibata H, Nawaz Z, Tsai SY, O’Malley BW, Tsai MJ (1997a) Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor ( SMRT ). Mol Endocrinol 11: 714–724Google Scholar
  84. Shibata H, Spencer TE, Oliate SA, Jenster G, Tsai SY, Tsai MJ, O’Malley BW (1997b) Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52:141 164: discussion 164–65Google Scholar
  85. Sjoberg M, Vennstrom B (1995) Ligand-dependent and -independent transactivation by thyroid hormone receptor 13–2 is determined by the structure of the hormone response element. Mol Cell Biol 15: 4718–4726PubMedGoogle Scholar
  86. Smith CL (1998) Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 58: 627–632PubMedGoogle Scholar
  87. Smith CL, Nawaz Z, O’Malley BW (1997) Coactivator and corepressor regulation of the agonistj antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11: 657–666PubMedGoogle Scholar
  88. Söderström M, Vo A, Heinzel T, Lavinsky RM, Yang WM, Seto E, Peterson DA, Rosenfeld MG, Glass CK (1997) Differential effects of nuclear receptor corepressor ( N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol Endocrinol 11: 682–692Google Scholar
  89. Starr DB, Matsui W, Thomas JR, Yamamoto KR (1996) Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Dev 10: 1271–1283PubMedGoogle Scholar
  90. Tagami T, Gu WX, Pcairs PT, West BL, Jameson JL (1998a) A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol 12: 1888–1902PubMedGoogle Scholar
  91. Tagami T, Lutz WH, Kumar R, Jameson JL (1998b) The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 253: 358–363PubMedGoogle Scholar
  92. Tagami T, Park Y, Jameson JL (1999) Mechanisms that mediate negative regulation of the thyroidstimulating hormone alpha gene by the thyroid hormone receptor. J Biol Chem 274: 22345–22353PubMedGoogle Scholar
  93. Tanenbaum DM, Wang Y, Williams SP, Sigler PB (1998) Crystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains. Proc Nat Acad Sci USA 95: 5998 — 6003PubMedGoogle Scholar
  94. Thummel CS (1995) From embryogenesis to metamorphosis: the regulation and function of Drosophila nuclear receptor superfamily members. Cell 83: 871–877PubMedGoogle Scholar
  95. Tsai MJ, O’Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Anna Rev Biochem 63: 451–486Google Scholar
  96. Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP (1998) The nuclear corepressors NCoR and SMRT are key regulators of both ligand-and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 18: 1369–1378PubMedGoogle Scholar
  97. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ (1995) A structural role for hormone in the thyroid hormone receptor. Nature 378: 690–697PubMedGoogle Scholar
  98. Weigel NL (1996) Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319: 657–667PubMedGoogle Scholar
  99. Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, Milburn MV, Rosenfeld MG, Glass CK (1998) Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395: 199–202PubMedGoogle Scholar
  100. Williams SP, Sigler PB (1998) Atomic structure of progesterone complexed with its receptor. Nature 393: 392–396PubMedGoogle Scholar
  101. Wolffe AP (1997) Transcriptional control. Sinful repression [news; comment]. Nature 387: 16–17PubMedGoogle Scholar
  102. Wong CW, Privalsky ML (1998a) Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARa, and BCL-6. J Biol Chem 273: 27695–27702PubMedGoogle Scholar
  103. Wong CW, Privalsky ML (1998b) Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol 18: 5500–5510PubMedGoogle Scholar
  104. Wong CW, Privalsky ML (1998c) Transcriptional silencing is defined by isoform-and heterodimerspecific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol 18: 5724–5733PubMedGoogle Scholar
  105. Xu L, Glass CK, Rosenfeld MG (1999) Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9: 140–147PubMedGoogle Scholar
  106. Yang Z, Hong SH, Privalsky ML (1999) Transcriptional antirepression: thyroid hormone receptor 13–2 recruits SMRT corepressor, but interferes with subsequent assembly of a functional corepressor complex. J Biol Chem 274: 37131–37138PubMedGoogle Scholar
  107. Yoh SM, Chatterjee VK, Privalsky ML (1997) Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11: 470–480PubMedGoogle Scholar
  108. Zamir I, Harding HP, Atkins GB, Hörlein A, Glass CK, Rosenfeld MG, Lazar MA (1996) A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16: 5458–5465PubMedGoogle Scholar
  109. Zamir I, Zhang J, Lazar MA (1997) Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev 11: 835–846PubMedGoogle Scholar
  110. Zhang J, Guenther MG, Carthew RW, Lazar MA (1998a) Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev 12: 1775–1780PubMedGoogle Scholar
  111. Zhang J, Hu X, Lazar MA (1999) A novel role for helix 12 of retinoid X receptor in regulating repression. Mol Cell Biol 19: 6448–6457PubMedGoogle Scholar
  112. Zhang J, Zamir I, Lazar MA (1997) Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression. Mol Cell Biol 17: 6887–6897PubMedGoogle Scholar
  113. Zhang X, Jeyakumar M, Petukhov S, Bagchi MK (1998b) A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12: 513–524PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • M. L. Privalsky
    • 1
  1. 1.Section of Microbiology, Division of Biological SciencesUniversity of California at DavisDavisUSA

Personalised recommendations